Position
Chief Executive Officer
Company
EIT Pharma
Description
EIT Pharma, a biotechnology company, continues to advance its late-stage infectious disease pipeline under the leadership of Dr. Leen Kawas. The company is focused on making significant strides in treating chronic hepatitis D and severe acute viral respiratory infections.
Quick answer
EIT Pharma Appoints Dr. Leen Kawas as Chief Executive Officer (August 12, 2026). EIT Pharma is based in Kirkland, Washington, United States.
- Who is the new Chief Executive Officer at EIT Pharma?
- EIT Pharma named Leen Kawas Chief Executive Officer, announced August 12, 2026.
- What did EIT Pharma announce on August 12, 2026?
- EIT Pharma, a biotechnology company, continues to advance its late-stage infectious disease pipeline under the leadership of Dr. Leen Kawas. The company is focused on making significant strides in treating chronic hepatitis D and severe acute viral respiratory infections.
- What does EIT Pharma do?
- EIT Pharma is a biotechnology company focusing on developing therapies for infectious diseases.
- Where is EIT Pharma based?
- EIT Pharma is based in Kirkland, Washington, United States.
- Which similar companies made leadership changes around the same time?
- Olema Oncology, Inc. (August 13, 2026), Kalohexis (August 11, 2026), City Therapeutics (August 11, 2026) and Olema Oncology (August 14, 2026) also announced leadership changes within 45 days of EIT Pharma.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Olema Pharmaceuticals Appoints Jason O’Byrne as Chief Financial Officer (August 13, 2026)
- Kalohexis Appoints Jeffrey Sherman as Chief Medical Officer (August 11, 2026)
- City Therapeutics Appoints Keith Regnante as Chief Financial Officer and Mary Beth DeLena as Chief Legal Officer (August 11, 2026)
- Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer (August 14, 2026)
- Neumora Therapeutics Names Joshua Pinto, Ph.D. as Chief Executive Officer (August 14, 2026)
- Innate Pharma Appoints Markus Jensen as Chief Medical Officer (August 10, 2026)
Who to call at EIT Pharma, and when
A new leader at EIT Pharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day EIT Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at EIT Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at EIT Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment EIT Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
EIT Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.